Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study	Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Malformations of Cortical Development, Group I, Neoplasms, Multiple Primary, brain disorder, central nervous system disorder, central nervous system malformation, cerebral cortical dysplasia, epilepsy, hamartoma, hereditary disease, hereditary neoplastic syndrome, inherited neurodegenerative disorder, neoplasm, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, tuberous sclerosis	Recruiting	Phase 2	2026-10-02		NCT05104983

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Darcy Krueger	1

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Boston Children's Hospital	Boston	United States	343
Children's Hospital Colorado	Aurora	United States	312
Cincinnati Children's Hospital Medical Center	Cincinnati	United States	405
Lurie Children's Hospital of Chicago	Chicago	United States	16
Seattle Children's Hospital	Seattle	United States	281
Stanford University	Palo Alto	United States	161
University of Alabama at Birmingham	Birmingham	United States	247
University of California at Los Angeles	Los Angeles	United States	14
University of North Carolina at Chapel Hill	Chapel Hill	United States	3
University of Texas HSC at Houston	Houston	United States	1
Washington University -- St. Louis	St Louis	United States	1